NEOSTIGMINE JUNO neostigmine methylsulfate 2.5 mg/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

neostigmine juno neostigmine methylsulfate 2.5 mg/1 ml solution for injection ampoule

juno pharmaceuticals pty ltd - neostigmine methylsulfate, quantity: 2.5 mg - injection, solution - excipient ingredients: water for injections; sodium chloride - neostigmine is indicated for:,? reversal of the effects of non-depolarising neuromuscular blocking agents.,? prophylaxis and treatment of post-operative intestinal atony and urinary retention.,? treatment of myasthenia gravis during acute exacerbations, when the condition is severe or in neonates.

Methylrosanilinium chloride 0.5% topical solution United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

methylrosanilinium chloride 0.5% topical solution

special order - methylrosanilinium chloride - cutaneous solution - 5mg/1ml

Methylrosanilinium chloride 2% topical solution United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

methylrosanilinium chloride 2% topical solution

special order - methylrosanilinium chloride - cutaneous solution - 20mg/1ml

Methylrosanilinium chloride 0.125% in Unguentum M cream United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

methylrosanilinium chloride 0.125% in unguentum m cream

special order - methylrosanilinium chloride - cutaneous cream - 1.25mg/1gram

ASTRAZENECA NEOSTIGMINE METHYLSULFATE 2.5mg/1mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca neostigmine methylsulfate 2.5mg/1ml injection ampoule

juno pharmaceuticals pty ltd - neostigmine methylsulfate -

NEOSTIGMINE JN neostigmine methylsulfate 0.5 mg/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

neostigmine jn neostigmine methylsulfate 0.5 mg/1 ml solution for injection ampoule

juno pharmaceuticals pty ltd - neostigmine methylsulfate, quantity: 500 microgram - injection, solution - excipient ingredients: sodium chloride; monobasic sodium phosphate; dibasic sodium phosphate dodecahydrate; water for injections - neostigmine is indicated for:,? reversal of the effects of non-depolarising neuromuscular blocking agents.,? prophylaxis and treatment of post-operative intestinal atony and urinary retention.,? treatment of myasthenia gravis during acute exacerbations, when the condition is severe or in neonates.

Crystal violet powder BP 1980 United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

crystal violet powder bp 1980

j m loveridge ltd - methylrosanilinium chloride - not applicable

Neostigmine Injection BP Australia - English - Department of Health (Therapeutic Goods Administration)

neostigmine injection bp

neostigmine methylsulfate -

Shiseido Sun Protection Compact Foundation(Refill)SP 60 - SPF 30+ Australia - English - Department of Health (Therapeutic Goods Administration)

shiseido sun protection compact foundation(refill)sp 60 - spf 30+

shiseido (australia) pty ltd - octyl methoxycinnamate,titanium dioxide -

Bonney's Blue 0.5%/0.5% paint BP 1980 United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bonney's blue 0.5%/0.5% paint bp 1980

extemp order - brilliant green; methylrosanilinium chloride; ethanol - cutaneous paint - 5mg/1ml ; 5mg/1ml ; 450microlitre/1ml